BPA Call HT001424A0002-HT001425F0050
Award Date
5/30/25
Potential Completion Date
5/30/25
Potential Value
$246K
Federal Agency
Defense Health Agency
Awardee
Sofie CO.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the Defense Health Agency to Sofie CO. for the supply of PYL-C PYLARIFY F-18 PIFLUFOLASTAT, a radiopharmaceutical product used for molecular imaging. The contract has a potential value of $497,918.84 and a completion date of January 19, 2024. Sofie CO. is the prime contractor, a for-profit organization that specializes in developing and delivering molecular diagnostics and therapeutics. The parent company is Sofie Biosciences, Inc., also a...
This federal contract award, valued at $25,261.04, was made by the Defense Health Agency (DHA) to Sofie CO., doing business as IBA Molecular, for the provision of radiopharmaceuticals needed for the treatment of prostate cancer patients with metastatic lesions. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type and an ultimate completion date of September 30, 2025. Sofie CO. is a subsidiary of Sofie Biosciences, Inc., a for-profit organization...
This federal contract award, valued at $822,788.16, was issued by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA) to Sofie CO., doing business as IBA Molecular. The contract is a firm fixed-price purchase order for the radiopharmaceutical product PYLARIFY, which is used for prostate cancer detection. Sofie CO. is a subsidiary of Sofie Biosciences, Inc., a specialized manufacturer and supplier of molecular diagnostics and therapeutics, with a...
This federal contract award is for the provision of PYLARIFY radiopharmaceuticals and related services to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2). The prime contractor is Sofie CO., a subsidiary of Sofie Biosciences, Inc. that specializes in the development and delivery of molecular diagnostics and therapeutics. The $1,681,341.42 firm-fixed-price delivery order contract supports the VA's medical imaging and cancer treatment programs, enabling the...
This federal contract award is to Sofie CO., a subsidiary of Sofie Biosciences, Inc., for the supply of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for prostate cancer detection. The $1,947,056.48 Firm Fixed Price contract was awarded by the Veterans Integrated Service Network 2 (VISN 2), a division of the Department of Veterans Affairs (VA). The contract has an ultimate completion date of December 31, 2024. Sofie Biosciences, Inc. is a specialized manufacturer and supplier of...
This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Sofie CO., doing business as IBA Molecular, to provide radiopharmaceuticals needed for the treatment of prostate cancer patients with metastatic lesions. The contract has a ceiling value of $21,652.32 and is effective through September 30, 2025. Sofie CO. is a subsidiary of Sofie Biosciences, Inc., a for-profit organization specializing in the development, production, and delivery of molecular diagnostics and...
This is a Blanket Purchase Agreement (BPA) call against the BPA master contract HT001421A0014 with Sofie CO. for PYLARIFY 71258-022-01 and PITFLUFOLASTAT F18, awarded by the Defense Health Agency (DHA). The contract is for the supply of specialized radiopharmaceuticals used in medical diagnostic procedures, with a focus on prostate cancer detection. The contract has a ceiling value of $87,400.00 and is a firm fixed-price contract. Sofie CO. is a subsidiary of Sofie Biosciences, Inc., a...
This is a delivery order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract, valued at $2,363,711.60, is for the ordering of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for prostate cancer detection. The contract has a period of performance through December 31, 2025 and is a firm fixed-price contract. Sofie is an established supplier of...
The Department of Veterans Affairs Veterans Health Administration awarded a $176,398.24 firm fixed price purchase order to Sofie CO. for the delivery of the radiopharmaceutical PYLARIFY. The contract has a completion date of May 31, 2022 and does not utilize a set-aside designation. Sofie CO. is a for-profit organization that specializes in developing and delivering molecular diagnostics and therapeutics, with extensive experience in PET imaging. The company has received multiple federal...
The federal contract award is for the supply of RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITE TREATMENT. The contract was awarded to Sofie CO., doing business as IBA Molecular, a for-profit organization specializing in the development and supply of molecular diagnostics and radiopharmaceuticals. The $28,869.76 firm fixed-price contract is a BPA Call awarded by the Defense Health Agency (DHA), a defense agency, to support medical imaging and...